Want to see GB:ELIX full AI Analyst Report?
Top Page
Elixirr International Plc
(LSE:ELIX)
Select Model
Select Model
Rating:72Outperform
Price Target:
559.00 p
▼(-10.99% Downside)
Action:Reiterated
Date:09/28/26
The score is driven primarily by strong underlying business performance and a very appealing valuation (low P/E and high dividend yield), reinforced by a positive earnings call highlighting record results and growth initiatives. These are offset by a weak technical setup (downtrend and bearish MACD) and financial watch items around higher leverage and softer operating cash flow support.
Positive Factors
Strong revenue and profit growth
Strong revenue and EBITDA growth indicates continued demand for Elixirr’s consulting and transformation services. The combination of top-line expansion and a 31% adjusted EBITDA margin provides resources to invest in capabilities, talent, and geographic reach over the next several quarters.
Negative Factors
Higher acquisition-driven leverage
The sharp increase in net debt reduces financial flexibility compared with Elixirr’s previously low-leverage profile. Higher borrowing also adds interest costs and makes future acquisition funding more dependent on cash generation, while management’s deleveraging target still needs to be delivered.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue and profit growth
Strong revenue and EBITDA growth indicates continued demand for Elixirr’s consulting and transformation services. The combination of top-line expansion and a 31% adjusted EBITDA margin provides resources to invest in capabilities, talent, and geographic reach over the next several quarters.
Read all positive factors
Elixirr International Plc (ELIX) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£249.65M
Dividend Yield4.56%
Average Volume (3M)160.98K
Price to Earnings (P/E)11.5
Beta (1Y)1.02
Revenue Growth28.85%
EPS Growth9.91%
CountryUK
Employees730
SectorIndustrials
Sector Strength72
IndustryConsulting Services
Share Statistics
EPS (TTM)0.43
Shares Outstanding50,853,348
10 Day Avg. Volume98,850
30 Day Avg. Volume160,979
Financial Highlights & Ratios
PEG Ratio1.18
Price to Book (P/B)2.76
Price to Sales (P/S)2.63
P/FCF Ratio12.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£1,167.50Price Target Upside85.91% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.65
Revenue Forecast (FY)£185.25M
Elixirr International Plc Business Overview & Revenue Model
Company Description
Elixirr International plc, along with its various subsidiaries, delivers expert management consulting services across the United Kingdom, the United States, and other international territories. The company's core offerings encompass creative strat...
How the Company Makes Money
Elixirr primarily makes money by delivering professional services to clients under consulting engagements. Revenue is generated from fees billed for advisory and delivery work (typically based on time-and-materials day rates or fixed-fee project s...
Elixirr International Plc Earnings Call Summary
Earnings Call Date:Sep 21, 2026
(Q2-2026)
| % Change Since: |
Next Earnings Date:Apr 05, 2027
Earnings Call Sentiment Positive
The call was strongly positive overall, with record H1 results, 25% revenue growth, 29% adjusted EBITDA growth, a 31% margin, 185% AI revenue growth, expanding client relationships, successful cross-selling, and continued capability and geographic expansion. The main challenges were the GBP 1.6 million FX headwind, completed programs affecting organic growth, low seasonal and acquisition-related cash flow, higher net debt, acquisition-related interest and share issuance, and an acknowledged valuation gap. Highlights significantly outweighed the lowlights.Positive Updates
Record H1 Financial Performance
H1 2026 revenue increased 25% to GBP 89.0 million, gross profit increased 26%, adjusted EBITDA increased 29% to GBP 27.6 million, and the adjusted EBITDA margin was 31.0%, up one percentage point on the prior comparable period.
Negative Updates
Foreign Exchange Headwind
A 4% weakening of the U.S. dollar relative to the pound created a GBP 1.6 million FX headwind in the period.
Read all updates
Q2-2026 Updates
Positive
Negative
Record H1 Financial Performance
H1 2026 revenue increased 25% to GBP 89.0 million, gross profit increased 26%, adjusted EBITDA increased 29% to GBP 27.6 million, and the adjusted EBITDA margin was 31.0%, up one percentage point on the prior comparable period.
Read all positive updates
Company Guidance
Management said the four pillar growth strategy remains the same: “We will continue to do organic growth,” “continue to deepen our client relationships,” “continue to do selective programmatic M&A,” and “look to sustain our premium margins”; the acquisition strategy “will be continuing,” and the company expects to “end the year with a significantly lower leverage position than the GBP 56.5 million” of net debt at H1 2026. The call also presented a scenario “where we have a 20% growth rate in revenue, EBITDA, and share price,” with the business becoming “broadly a GBP 1 billion market cap business by 2031,” with “18% dilution” and existing shareholders owning “roughly GBP 850 million” and “3x the value that it is today.”Elixirr International Plc Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
76
Positive
Cash Flow
72
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 167.15M | 149.60M | 111.34M | 85.89M | 71.75M | 50.61M |
| Gross Profit | 49.50M | 44.80M | 35.81M | 29.26M | 23.16M | 17.70M |
| EBITDA | 44.97M | 39.55M | 27.96M | 25.78M | 20.02M | 14.46M |
| Net Income | 21.02M | 19.70M | 16.38M | 17.24M | 12.87M | 10.14M |
Balance Sheet | ||||||
| Total Assets | 272.98M | 251.08M | 175.89M | 154.40M | 128.66M | 107.17M |
| Cash, Cash Equivalents and Short-Term Investments | 2.52M | 5.05M | 7.53M | 18.13M | 20.43M | 31.80M |
| Total Debt | 63.55M | 33.52M | 4.90M | 5.36M | 5.14M | 5.25M |
| Total Liabilities | 120.23M | 108.56M | 43.78M | 34.84M | 32.74M | 21.13M |
| Stockholders Equity | 152.75M | 142.53M | 132.11M | 119.56M | 95.92M | 86.04M |
Cash Flow | ||||||
| Free Cash Flow | 25.52M | 31.48M | 28.76M | 16.67M | 15.40M | 14.23M |
| Operating Cash Flow | 25.57M | 31.55M | 28.84M | 16.79M | 15.73M | 14.33M |
| Investing Cash Flow | -55.17M | -36.56M | -21.11M | -14.82M | -18.53M | -3.24M |
| Financing Cash Flow | 29.47M | 2.92M | -18.58M | -4.06M | -8.85M | 3.11M |
Elixirr International Plc Technical Analysis
Negative
628.00
Price Trends
546.30
Negative
602.47
Negative
646.69
Negative
Market Momentum
-12.03
Negative
42.12
Neutral
64.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Negative. The current price of 628 is above the 20-day moving average (MA) of 505.05, above the 50-day MA of 546.30, and below the 200-day MA of 646.69, indicating a bearish trend. The MACD of -12.03 indicates Negative momentum. The RSI at 42.12 is Neutral, neither overbought nor oversold. The STOCH value of 64.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:ELIX.
Elixirr International Plc Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | £249.65M | 11.53 | 14.24% | 4.56% | 28.85% | 9.91% | |
68 Neutral | £2.75B | 18.75 | 17.55% | 1.61% | 1.20% | 221.80% | |
67 Neutral | £318.49M | 55.89 | 3.05% | 3.40% | 1.98% | -57.39% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | £421.66M | 13.31 | 12.09% | 2.33% | 8.63% | 139.90% | |
61 Neutral | £98.18M | 31.78 | 4.61% | 7.41% | 8.23% | 118.63% | |
47 Neutral | £307.23M | -1.54 | -677.10% | 5.94% | -16.13% | -1315.87% |
* Industrials Sector Average
GB:ELIX
Elixirr International Plc
496.00
-321.02
-39.29%
GB:CPI
Capita plc
256.50
-56.50
-18.05%
GB:GTLY
Gateley (Holdings)
71.50
-34.86
-32.78%
GB:DATA
GlobalData
64.40
-42.13
-39.55%
GB:SRP
Serco Group plc
288.20
38.54
15.44%
GB:YOU
Yougov plc
272.20
19.76
7.83%
Elixirr International Plc Corporate Events
Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and Compliance
Elixirr Clarifies Line‑Up of Joint Corporate Brokers
Positive
Sep 22, 2026
Elixirr International plc is an award‑winning global consulting firm that positions itself as a challenger to traditional large corporate consultancies. Founded in 2009, it serves clients across diverse industries and geographies and has exp...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Elixirr Delivers Record Half-Year as AI Work and Major Client Growth Accelerate
Positive
Sep 21, 2026
Elixirr International reported record interim results for the six months to 30 June 2026, with revenue rising 25% to £89.0m and adjusted EBITDA up 29% to £27.6m, lifting the margin to 31%. Adjusted profit before tax increased 25% to ...
Business Operations and StrategyFinancial Disclosures
Elixirr Sets September Dates for H1 2026 Results and Investor Presentation
Positive
Sep 15, 2026
Elixirr International plc will publish its half-year results for the period ended 30 June 2026 on 21 September and follow up with a live investor presentation on 23 September via the Investor Meet Company platform. The event, open to existing and ...
Business Operations and StrategyExecutive/Board ChangesFinancial Disclosures
Elixirr Posts Record H1 Results and Bolsters U.S. Push with New Broker
Positive
Aug 3, 2026
Elixirr International, a global challenger consulting firm focused on commercial transformation, technology and AI services, reported strong growth for the first half of 2026, highlighting its expanding role in AI-enabled consulting. The London-li...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Elixirr CFO Exercises Share Options Without Diluting Equity
Positive
Jul 10, 2026
Elixirr International Plc reported that Chief Financial Officer and Company Secretary Nicholas Willott has exercised options over 100,000 ordinary shares at an exercise price of 43.365p per share, with the shares sourced from the company’s E...
Business Operations and StrategyShareholder Meetings
Elixirr Wins Strong Shareholder Backing as All AGM Resolutions Pass
Positive
Jun 30, 2026
Elixirr International plc, the award-winning challenger consultancy, operates globally across diverse sectors and focuses on collaborative, outcome-driven advisory services that differentiate it from larger incumbents. Since its 2009 founding, the...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.